Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.3565
-0.0145 (-3.91%)
At close: Jan 29, 2026, 4:00 PM EST
0.3613
+0.0048 (1.35%)
After-hours: Jan 29, 2026, 4:04 PM EST
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $32.53 million as of January 29, 2026. Its market cap has decreased by -61.69% in one year.
Market Cap
32.53M
Enterprise Value
19.60M
1-Year Change
-61.69%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $32.53M, a decrease of -83.19%. That is a compound annual growth rate of -19.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 29.20M | 21.67% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reviva Pharmaceuticals Holdings | 35.28M |
| Kyntra Bio | 34.51M |
| Pluri | 34.02M |
| Skye Bioscience | 32.70M |
| Outlook Therapeutics | 32.56M |
| Evaxion | 32.53M |
| AN2 Therapeutics | 32.47M |
| Exicure | 32.19M |